| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 |
|---|---|---|---|---|---|---|
Cash flows from operating activities | ||||||
Net loss | ||||||
0 | 0 | 0 | - | 0 | 0 | 0 |
Adjustment to reconcile net loss to net cash used in operating activities: | ||||||
Bad debt expense | ||||||
1,122 | 968 | 550 | 345 | 0 | 0 | 0 |
Stock-based compensation expense | ||||||
0 | 0 | 0 | - | - | - | - |
Changes in operating assets and liabilities: | ||||||
Accounts receivable | ||||||
1,261 | 2,650 | 3,329 | 1,669 | 0 | 0 | 0 |
Prepaid expenses and other current assets | ||||||
1,308 | 810 | 476 | 351 | 0 | 0 | 0 |
Accounts payable | ||||||
- | 0 | 0 | - | - | 0 | 0 |
Accounts payable and accrued liabilities | ||||||
288 | -146 | 79 | 126 | 0 | 0 | 0 |
Deferred revenue | ||||||
-162 | 503 | 70 | 154 | 0 | 0 | 0 |
Net cash used in operating activities | ||||||
-14,292 | -12,642 | -11,761 | -9,048 | 0 | 0 | 0 |
Cash flows from financing activities | ||||||
Cash received in connection with exercise of warrants | ||||||
0 | 0 | 0 | - | - | - | - |
Cash received in connection with issuance of shares | ||||||
- | - | - | 10,000 | 0 | 0 | 0 |
Net cash provided by financing activities | ||||||
4,247 | 4,247 | 4,242 | 10,000 | 0 | 0 | 0 |
Net change in cash and restricted cash | ||||||
8,595 | 10,197 | 11,324 | 19,794 | 0 | 0 | 0 |
Cash paid for interest | ||||||
- | 0 | 0 | - | - | 0 | 0 |